Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 20/07/2026
In
Objective
To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
AIC sector
Management group
Company website
Launch date
29/10/2019
December
Domicile
Guernsey
Fund manager
Naveen Yalamanchi, Roderick Wong, Woody Stileman, Oliver Kenyon
Dividend frequency
N/A
Wind-up provisions
The Company has an unlimited life.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 786.46 | 921.84 | 2.44 | 2.86 | -14.69 | 0 | 0.00 | N/A | 1.74 (31/12/2025) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| RTW Biotech Opportunities | Share price total return | 86.2 | 82.7 | 18.0 | N/A |
| Healthcare & Biotechnology AIC sector | Share price total return | 37.2 | 20.3 | -1.5 | 96.7 |
Scroll
Share structure
Number of shares
322,321,264
23,546,176
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 55,231 | 12,001,779 | 184,145,345 | 417,597,213 |
| Average | N/A | 571,513 | 727,847 | 331,164 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.13 | 28.31 | 346.47 | 664.20 |
| Average | N/A | 1.35 | 1.37 | 0.53 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GG00BKTRRM22 | RTW | USD | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 31/12/2025
| Investment | % of total assets |
|---|---|
| Other Assets | 22.6 |
| Ptct | 12.9 |
| CORXEL Pharmaceuticals | 6.2 |
| Stok | 5.2 |
| Urgn | 5.0 |
| Insm | 3.9 |
| Kailera Therapeutics | 3.4 |
| Tars | 2.8 |
| Imtx | 2.7 |
| Argx | 2.2 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.